Gilead Sciences
GILD • NASDAQ
Gilead Sciences is a drug manufacturers - general company in the healthcare sector trading on NASDAQ, led by CEO Daniel O'Day, with a market cap of $176.36B.
Market Cap$176.36B
Employees18.0K
CEODaniel O'Day
CountryUnited States of America
Healthcare
Drug Manufacturers - General
Next EarningsApr 23, 2026 · In 1 weekQ1 2026
Financials
Gilead Sciences FAQ
Common questions about Gilead Sciences
Gilead Sciences is scheduled to report earnings for Q1 2026 on April 23, 2026. Analysts estimate revenue of $6.9B.
Gilead Sciences has approximately 18,000 employees.